<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03105154</url>
  </required_header>
  <id_info>
    <org_study_id>15-1402</org_study_id>
    <nct_id>NCT03105154</nct_id>
  </id_info>
  <brief_title>Groin Wound Infection Rate Using Prevena Compared to Standard Dressing in Vascular Surgery Patients With High Risk</brief_title>
  <acronym>PREVENA</acronym>
  <official_title>Experience With the Negative Pressure Incision Management System (Prevena) in Vascular Surgery Patients With High Risk for Groin Wound Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate wound healing using Prevena compared to standard dressings in high risk patients&#xD;
      after vascular surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients submitted to bilateral femoral endarterectomy will have one groin dressed with&#xD;
      PrevenaTM and the contralateral one dressed with conventional bandage immediately after&#xD;
      suture. Both PrevenaTM and the conventional bandage at the contralateral side will be removed&#xD;
      before the patient discharge. Groin wound complications such as deep space infection,&#xD;
      cutaneous cellulitis, dehiscence or re-interventions for wound-related complications will be&#xD;
      observed in a 30-day evaluation window. This observation will be performed during the patient&#xD;
      admission and in the post-operative standard of care visits among the first 30 days.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2016</start_date>
  <completion_date type="Actual">November 10, 2020</completion_date>
  <primary_completion_date type="Actual">November 10, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patient will be randomized sequentially to Prevena alternating with standard of care dressing</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>% of infection at 30 days</measure>
    <time_frame>30 days</time_frame>
    <description>% of wound occurrence in the Prevena treated groin compared to conventional treated groin</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">27</enrollment>
  <condition>Endovascular Procedures</condition>
  <arm_group>
    <arm_group_label>Prevena Dressing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Groin dressed with Prevena</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional Dressing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Groin dressed with conventional bandage</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Prevena Dressing</intervention_name>
    <description>Prevena dressing is applied on one groin</description>
    <arm_group_label>Prevena Dressing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Conventional Dressing</intervention_name>
    <description>Conventional dressing is applied on the contralateral groin</description>
    <arm_group_label>Conventional Dressing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with known bilateral vascular peripheral disease who are being evaluated for&#xD;
             possible bilateral femoral endarterectomy&#xD;
&#xD;
          -  Patients with one or more risk factor (diabetes mellitus, Obesity, heavy smoker,&#xD;
             immunodeficiency disease, groin reoperation, prosthetic)&#xD;
&#xD;
          -  Patients in follow-up at Clinic in the Vascular Surgery Department&#xD;
&#xD;
          -  Sign of informed consent&#xD;
&#xD;
          -  English speaking&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Refusal to participate&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  unilateral femoral endarterectomy&#xD;
&#xD;
          -  subjects for whom Prevena IMS is contraindicated&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leveser Kirksey</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clevealnd Clnic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>March 14, 2017</study_first_submitted>
  <study_first_submitted_qc>April 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 7, 2017</study_first_posted>
  <last_update_submitted>February 10, 2021</last_update_submitted>
  <last_update_submitted_qc>February 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Cleveland Clinic</investigator_affiliation>
    <investigator_full_name>Levester Kirksey</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wound Infection</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

